// App-Quantinova.ai

10038 : Anti-PD1 antibodies in late elderly advanced melanoma patients: A retrospective multicentre study.

Researchers

Presenter

  • Francesco De Rosa

Principal Investigators

  • Enrica Teresa Tanda

  • Elena Marra

  • Jacopo Pigozzo

  • Riccardo Marconcini

  • Michele Guida

  • Giulia Gallizzi

  • Marcella Occelli

  • Laura Pala

  • Elisabetta Gambale

  • Melissa Bersanelli

  • Raffaele Conca

  • Alessio Cortellini

  • Francesca Morgese

  • Federica Zoratto

  • Luigia Stefania Stucci

  • Sabino Strippoli

  • Elisabetta Petracci

  • Massimo Guidoboni

Medical Centers

  • Immunotherapy, Cell Therapy and Biobank, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola (FC), Italy

  • Department of Medical Oncology, San Martino Polyclinic, Genova, Italy

  • Dermatology Clinic, University of Turin, Turin, Italy

  • Melanoma and Esophageal Oncology Unit, Veneto Institute of Oncology IOV IRCCS, Padua, Italy

  • Medical Oncology, University of Pisa, Pisa, Italy

  • Medical Oncology Department National Cancer Research Centre "Giovanni Paolo II", Bari, Italy

  • Oncology, SS Antonio e Biagio General Hospital, Alessandria, Italy

  • Medical Oncology, S.Croce & Carle Teaching Hospital, Cuneo, Italy

  • Division of Medical Oncology for Melanoma & Sarcoma, European Institute of Oncology, Milan, Italy

  • Department of Medical Oncology, University of Chieti, Chieti, Italy

  • Medical Oncology Unit, University Hospital of Parma, Parma, Italy

  • Unit of Medical Oncology, Department of Onco-Hematology, IRCCS-CROB Referral Cancer Center of Basilicata, Rionero in Vulture (PZ), Italy

  • Medical Oncology, St Salvatore Hospital, Department of Biotechnological and Applied Clinical Sciences, University of LAquila, L'aquila, Italy

  • Oncology Clinic, Universita Politecnica delle Marche, Ancona, Italy

  • Oncology, Frosinone Hospital, Frosinone, Italy

  • Oncology Clinic, University of Bari, Bari, Italy

  • Medical Oncology, Barletta Hospital, Barletta, Italy

  • Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Pembrolizumab

  • Nivolumab

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved